Beacon Investment Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Beacon Investment Advisory Services's EW Position: Q2 2026 in Review
Beacon Investment Advisory Services sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 75 shares — an estimated $6.01K sold.
Beacon Investment Advisory Services first reported a position in EW in Q1 2020 and held it in 20 quarters. The position peaked at $8.07M in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Beacon Investment Advisory Services reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Beacon Investment Advisory Services sold 75 Edwards Lifesciences shares in Q2 2026, an estimated $6.01K.
- Beacon Investment Advisory Services first reported a position in Edwards Lifesciences in Q1 2020 and held it in 20 quarters.
- Beacon Investment Advisory Services's Edwards Lifesciences position peaked at $8.07M in Q4 2021.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.